用于检测青光眼性视野异常的各种簇标准特异性研究
本研究纳入384名健康参与者的607眼和345名青光眼参与者的501眼,评估常用视野簇标准定义青光眼性视野异常的特异性及标准变化的影响。各簇标准的假阳性率在9%至46%之间,仅要求异常在同一位置可重复的标准假阳性率≤6%;簇标准检测青光眼的表现通常与模式标准差(PSD)相似或更差。
要点
- 常用视野簇标准的假阳性率在9%至46%之间,随定义不同而差异很大。
- 仅要求异常在同一位置可重复的标准假阳性率≤6%。
- 各簇标准检测青光眼眼的表现通常与PSD相似或更差。
核心结论
- 常用视野簇标准假阳性率高且随定义变化大,设计及解读青光眼临床研究时需仔细考虑所用标准。
研究设计与样本
- 观察性研究,纳入384名健康参与者的607眼和345名青光眼参与者的501眼,每眼至少两次可靠的24-2视野检查。
- 异常视野簇定义为≥3个连续异常位点,并评估基于总偏差和/或模式偏差、异常位点的概率截断值、以及异常是否需可重复(同一半野或同一位置)等定义变化。
- 各定义还与模式标准差(PSD)值进行比较。
主要发现
- 各簇标准的假阳性率在9%至46%之间,取决于具体定义。
- 仅要求异常在同一位置可重复的定义达到假阳性率≤6%。
- 各簇标准检测青光眼眼的表现通常与PSD值相似或更差。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to evaluate the specificity of commonly used cluster criteria for defining the presence of glaucomatous visual field abnormalities and the impact of variations in the criterion used. METHODS: This is an observational study including 607 eyes from 384 healthy participants, and 501 eyes of 345 participants with glaucoma, with at least two reliable 24-2 visual field tests. An abnormal visual field cluster was defined as the presence of ≥3 contiguous abnormal locations. Variations in this definition were evaluated and included (1) whether abnormalities were based on total deviation and/or pattern deviation values; (2) probability cut-off for defining an abnormal location; and (3) whether abnormalities were required to be repeatable (within the same hemifield or at the same locations) or not. These definitions were also compared against pattern standard deviation (PSD) values. RESULTS: False-positive rates of various cluster criteria ranged between 9% and 46% depending on the specific definitions used. Only definitions that required abnormalities to be repeatable at the same location achieved a false-positive rate of ≤6%. The various cluster criteria generally performed similarly or worse at detecting glaucoma eyes compared with the PSD values. CONCLUSIONS: Commonly used visual field cluster criteria have high false-positive rates that vary widely depending on the definition used. These findings highlight the need to carefully consider the criteria used when designing and interpreting glaucoma clinical studies. TRIAL REGISTRATION NUMBER: NCT00221923.
引用
- Wu Z, Medeiros FA, Weinreb RN, et al. Specificity of various cluster criteria used for the detection of glaucomatous visual field abnormalities. Br J Ophthalmol. 2019. PMID: 31530565. doi:10.1136/bjophthalmol-2019-314593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。